NCT06197841View on ClinicalTrials.gov

Neurofilament Light Chain as Diagnostic and Prognostic Marker in naïve Multiple Sclerosis Patients

Enrolling by invitationOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 31, 2024

Conditions
Role of Neurofilment in Diagnosis of Multiple Sclerosis
Trial Locations (1)

Unknown

Ahmed El menshawy, Asyut

All Listed Sponsors
collaborator

Al-Azhar University

OTHER

lead

Assiut University

OTHER